- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/28 - Insulins
Patent holdings for IPC class A61K 38/28
Total number of patents in this class: 2631
10-year publication summary
232
|
213
|
242
|
259
|
246
|
220
|
196
|
181
|
181
|
79
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
MannKind Corporation | 522 |
120 |
Novo Nordisk A/S | 2290 |
116 |
Eli Lilly and Company | 3825 |
67 |
Adocia | 141 |
62 |
Rani Therapeutics, LLC | 199 |
55 |
Case Western Reserve University | 1804 |
54 |
Sanofi-Aventis Deutschland GmbH | 2636 |
50 |
Hanmi Pharm. Co., Ltd. | 569 |
47 |
Sanofi | 4021 |
40 |
Merck Sharp & Dohme LLC | 3743 |
36 |
Insulet Corporation | 825 |
33 |
Medtronic MiniMed, Inc. | 1790 |
32 |
Halozyme, Inc. | 136 |
32 |
Merck Sharp & Dohme Corp. | 2201 |
25 |
North Carolina State University | 1554 |
25 |
Boehringer Ingelheim International GmbH | 4698 |
24 |
SDG, Inc. | 31 |
24 |
Massachusetts Institute of Technology | 10019 |
23 |
The Brigham and Women's Hospital, Inc. | 2174 |
21 |
Indiana University Research and Technology Corporation | 796 |
21 |
Other owners | 1724 |